Chemed Co. (NYSE:CHE – Get Free Report) CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $569.63, for a total transaction of $1,139,260.00. Following the completion of the transaction, the chief executive officer now directly owns 105,735 shares in the company, valued at $60,229,828.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Chemed Price Performance
Shares of Chemed stock traded up $9.50 during trading on Tuesday, hitting $577.80. The company’s stock had a trading volume of 70,924 shares, compared to its average volume of 88,054. Chemed Co. has a 52 week low of $492.84 and a 52 week high of $654.62. The stock has a market cap of $8.75 billion, a price-to-earnings ratio of 30.50, a price-to-earnings-growth ratio of 2.40 and a beta of 0.43. The stock has a 50-day moving average price of $544.78 and a two-hundred day moving average price of $582.79.
Chemed (NYSE:CHE – Get Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same period in the prior year, the firm earned $4.71 EPS. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, equities analysts predict that Chemed Co. will post 21.77 EPS for the current fiscal year.
Chemed Increases Dividend
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the stock. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Royal Bank of Canada decreased their target price on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 21st.
Read Our Latest Stock Report on CHE
Institutional Trading of Chemed
Several hedge funds have recently modified their holdings of the stock. Wealth Alliance grew its holdings in Chemed by 3.0% in the fourth quarter. Wealth Alliance now owns 578 shares of the company’s stock worth $338,000 after purchasing an additional 17 shares during the period. EntryPoint Capital LLC grew its holdings in Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after purchasing an additional 18 shares during the period. Signaturefd LLC grew its holdings in Chemed by 5.8% in the fourth quarter. Signaturefd LLC now owns 385 shares of the company’s stock worth $225,000 after purchasing an additional 21 shares during the period. Covestor Ltd grew its holdings in Chemed by 10.6% in the first quarter. Covestor Ltd now owns 219 shares of the company’s stock worth $141,000 after purchasing an additional 21 shares during the period. Finally, Ballentine Partners LLC grew its holdings in Chemed by 3.4% in the first quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock worth $424,000 after purchasing an additional 22 shares during the period. Institutional investors own 95.85% of the company’s stock.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
- Five stocks we like better than Chemed
- How Investors Can Find the Best Cheap Dividend Stocks
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- 10 Best Airline Stocks to Buy
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- Consumer Staples Stocks, Explained
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.